Navigation Links
AbbVie to Host Third-Quarter Earnings Conference Call
Date:10/6/2015

NORTH CHICAGO, Ill., Oct. 6, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2015 financial results on Friday, Oct. 30, 2015, before the market opens.

AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern). It will be accessible through AbbVie's Investor Relations website at www.abbvieinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

 


'/>"/>
SOURCE AbbVie
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
2. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
3. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
4. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
5. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
6. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
7. AbbVie Declares Quarterly Dividend
8. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
9. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
10. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
11. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2019)... ... January 19, 2019 , ... Omolara ... expanded her service offerings to include the latest and most advanced CoolSculpting technology ... for patients. , Dr. Otaigbe is committed to providing leading, state-of-the-art, non-invasive ...
(Date:1/15/2019)... , ... January 15, 2019 , ... ... new course locations for the 2019 Wound Certification Prep Course (WCPC), the leading ... possess increased specialized knowledge in wound management, WCPC will be expanding its course ...
(Date:1/14/2019)... ... January 14, 2019 , ... USpharma Ltd announced ... the U.S. market. Bayer Consumer Care AG and its affiliates (collectively “Bayer”) ... brand to USpharma. Since first being introduced in 1950, Cushion Grip was ...
Breaking Medicine Technology:
(Date:1/14/2019)... (PRWEB) , ... January 14, 2019 , ... Yes, the ... survey by the International Council on Active Aging® (ICAA), new tech is also finding ... Visions of the Future , queried respondents from a variety of organizations that work ...
(Date:1/14/2019)... , ... January 14, 2019 , ... Trees can be ... reasons homeowners should have trees pruned, and winter is a great time to clean ... deadwood branches can lead to serious damage, especially during windy or icy storms. The ...
(Date:1/13/2019)... ... 2019 , ... On December 13th, The Pennsylvania Athletic Trainers’ ... continuing education (CEU) event entitled, Can You Hear Me Now? Creating and Improving ... of talks to help develop and cultivate the relationship between mentors and mentees. ...
(Date:1/11/2019)... ... January 11, 2019 , ... Ms. Barrios, a ... the U.S., alleges that Andrews and others engaged in a systematic pattern of ... referred to employees by race and by the color of their skin, and ...
(Date:1/10/2019)... ... 2019 , ... Net-Translators, an industry-leading provider of medical ... company that serves the medical industry. The companies naturally complement each other’s solutions ... and healthcare industries. Based in France, they join Net-Translators’ program of partners from ...
Breaking Medicine News(10 mins):